当前位置:首页 - 行情中心 - 易瑞生物(300942) - 财务分析

易瑞生物

(300942)

  

流通市值:44.23亿  总市值:44.23亿
流通股本:4.05亿   总股本:4.05亿

易瑞生物(300942)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.02亿元,每股收益0.01元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益86542.03万元,未分配利润14897.31万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产142015.44万元,负债55473.41万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入109,287,425.2249,342,908.97224,249,109.55158,047,893.25
营业总成本109,966,393.4555,561,251.36210,280,739.07158,868,141.37
其他经营收益
营业利润460,431.88-5,028,196.9620,964,977.155,067,489.74
利润总额645,747.18-5,034,645.8719,689,062.564,719,186.18
净利润1,889,832.3-4,233,747.8916,619,408.292,987,228.32
每股收益
其他综合收益35,823.62-209,889.51-171,733.24-64,861.63
综合收益总额1,925,655.92-4,443,637.416,447,675.052,922,366.69
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计702,228,403.82730,932,473.54751,616,151.89733,305,067.2
非流动资产:
非流动资产合计717,925,976.71712,143,133705,549,784.03645,452,138.3
资产总计1,420,154,380.531,443,075,606.541,457,165,935.921,378,757,205.5
流动负债:
流动负债合计109,475,500.98133,697,567.35151,957,740.25141,701,800.07
非流动负债:
非流动负债合计445,258,578.95443,029,682.04434,965,624.69383,339,512.28
负债合计554,734,079.93576,727,249.39586,923,364.94525,041,312.35
所有者权益(或股东权益):
归属于母公司股东权益合计864,392,737.31865,758,868.6869,005,338.22852,891,282.94
股东权益合计865,420,300.6866,348,357.15870,242,570.98853,715,893.15
负债和股东权益合计1,420,154,380.531,443,075,606.541,457,165,935.921,378,757,205.5
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计129,013,940.767,267,138.19258,281,157.09183,656,359.44
经营活动现金流出小计129,034,293.1668,682,372.66224,022,954.49167,624,881.56
经营活动产生的现金流量净额-20,352.46-1,415,234.4734,258,202.616,031,477.88
投资活动产生的现金流量:
投资活动现金流入小计382,285,490.65219,005,301.56761,504,554.64548,771,260
投资活动现金流出小计257,264,464.6758,284,905.241,109,021,770.45864,388,277.17
投资活动产生的现金流量净额125,021,025.98160,720,396.32-347,517,215.81-315,617,017.17
筹资活动产生的现金流量:
筹资活动现金流入小计5,928,827.625,928,827.62112,414,358.0352,000,000
筹资活动现金流出小计46,129,653.355,272,686.8525,275,562.3320,326,577.48
筹资活动产生的现金流量净额-40,200,825.73656,140.7787,138,795.731,673,422.52
汇率变动对现金及现金等价物的影响4,472,755.281,792,812.671,503,302.13-932,712.5
现金及现金等价物净增加额89,272,603.07161,754,115.29-224,616,915.38-268,844,829.27
期末现金及现金等价物余额346,404,562.49418,886,074.71257,131,959.42212,754,799.4
补充资料:
现金及现金等价物的净增加额89,272,603.07--224,616,915.38-
TOP↑